Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,459.10
+4.50 (0.31%)
At close: Dec 5, 2025
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 370.18 billion as of December 5, 2025. Its market cap has decreased by -6.87% in one year.
Market Cap
370.18B
Enterprise Value
384.81B
Revenue
93.59B
Ranking
n/a
PE Ratio
43.25
Stock Price
1,459.10
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 370.18B, an increase of 11,400.73%. That is a compound annual growth rate of 22.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 370.18B | -13.93% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | 277.65B | 93.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.36T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 710.38B |
| Alkem Laboratories | 676.62B |